KARACHI: A leading pharmaceuticals company of Pakistan, the Searle Company Ltd, has announced that it is acquiring OBS Pakistan Ltd, a statement said on Tuesday.
Searle had been a US-based multinational company, as it was acquired by IBL Group in 1993 and listed at the Pakistan Stock Exchange.
The latest acquisition will strengthen the Searle's portfolio, enabling the company to bring research molecules in the Pakistani pharmaceutical market. Searle is well known in the country for high quality and economical pharmaceutical products.
OBS Pakistan Ltd, is a strategic pharmaceutical organisation comprising global multinational pharmaceutical companies such as Organon, Merck & Co Inc USA, Schering Plough, Santen Japan and Vifor Switzerland.
Its international brands are well established in Pakistan, as they are widely prescribed by the medical doctors across the country. This acquisition will change the Searle's ranking and provide it with more market penetration.
Chinese power company had intended to acquire up to 18.336 billion ordinary shares of K-Electric, representing 66.4...
MARI also successfully drilled and tested another appraisal well in the Mari Ghazij formation located in Mari D&PL
Gold rates decreased by $30 to $2,381 per ounce in the international market
Growing number of Americans have seen their savings dwindle as rising prices squeeze budgets while interest rates stay...
IMF will closely watch the privatization of PIA by the end of June
PSX lays down the groundwork to encourage listed companies to adopt ESG reporting in line with global standards
